Managed Competition in Healthcare (?); Comment on “Measuring Active Purchasing in Healthcare: Analysing Reallocations of Funds Between Providers to Evaluate Purchasing Systems Performance in the Netherlands”

Document Type : Commentary

Author

Faculty of Economics and Administration, Masaryk University Brno, Brno, Czechia

Abstract

This article comments on the paper by Stadhouders et al titled “Measuring Active Purchasing in Healthcare: Analysing Reallocations of Funds Between Providers to Evaluate Purchasing Systems Performance in the Netherlands.” Its main aim is to respond to the fact that the paper, without discussion, assumes that competitive reform stimulates the efficient allocation of funds. To achieve this goal, this article discusses existing knowledge related to the author’s assumption, highlighting that there is no uniform theory regarding the capacity of market forces to regulate healthcare markets. It also argues that market-based healthcare reforms may be very risky in countries with limited state regulatory capacity and widespread corruption. 

Keywords


  1. Stadhouders NW, Koolman X, Tanke MAC, Maarse H, Jeurissen PPT. Measuring active purchasing in healthcare: analysing reallocations of funds between providers to evaluate purchasing systems performance in the Netherlands. Int J Health Policy Manag. 2023;12:7506. doi:34172/ijhpm.2023.7506
  2. Enthoven AC. Health Plan: The Only Practical Solution to the Soaring Costs of Medical Care. Reading, MA: Addison-Wesley; 1980.
  3. Enthoven AC. The history and principles of managed competition. Health Aff (Millwood). 1993;12(suppl 1):24-48. doi:1377/hlthaff.12.suppl_1.24
  4. Enthoven AC. Why competition in health care has failed: what would it take to make it work? Clemens Lecture Series. 1992;6.
  5. Klein R. Big bang health care reform: does it work?: the case of Britain's 1991 National Health Service reforms. Milbank Q. 1995;73(3):299-337. doi:2307/3350335
  6. Andritsos DA, Tang CHS. Introducing competition in healthcare services: the role of private care and increased patient mobility. Eur J Oper Res. 2014;234(3):898-909. doi:1016/j.ejor.2013.11.022
  7. Lieverdink H. The marginal success of regulated competition policy in the Netherlands. Soc Sci Med. 2001;52(8):1183-1194. doi:1016/S0277-9536(00)00238-0
  8. Arrow KJ. Uncertainty and the welfare economics of medical care. Am Econ Rev. 1963;53(3):941-973.
  9. Saltman R, Figueras J. European Health Care Reform: Analysis of Current Strategies. Copenhagen: World Health Organization, Regional Office for Europe; 1997:285.

Articles in Press, Corrected Proof
Available Online from 15 July 2025
  • Received Date: 18 March 2025
  • Revised Date: 24 June 2025
  • Accepted Date: 14 July 2025
  • First Published Date: 15 July 2025